Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Spinal Cord Injury
  4. Elevated levels of IgA and IgG2 in individuals with chronic spinal cord injury

Elevated levels of IgA and IgG2 in individuals with chronic spinal cord injury

The Journal of Spinal Cord Medicine, 2022 · DOI: 10.1080/10790268.2020.1854550 · Published: January 1, 2022

Spinal Cord InjuryImmunology

Simple Explanation

This study investigated the levels of different types of antibodies in individuals with chronic spinal cord injury (SCI) compared to those without SCI. Infections are a major cause of rehospitalization and death for individuals with SCI, highlighting the importance of understanding their immune responses. The researchers found that individuals with chronic SCI had significantly higher levels of IgA and IgG2 antibodies in their blood compared to uninjured individuals. IgA is commonly found at mucosal surfaces, which are frequent sites of infection in individuals with SCI. These findings suggest that the immune system in individuals with chronic SCI is altered, with potentially important implications for their susceptibility to infections and responses to emerging infectious diseases. Further research is needed to understand the role of these antibodies in SCI and their impact on health outcomes.

Study Duration
2009-2016
Participants
29 individuals with chronic SCI and 25 uninjured individuals
Evidence Level
Prospective, observational study

Key Findings

  • 1
    IgA levels were significantly elevated in participants with chronic SCI compared to uninjured participants (median: 1.98 vs. 1.21 mg/ml, P < 0.0001).
  • 2
    IgG2 antibodies were also significantly elevated in participants with SCI compared to uninjured participants (median: 5.98 vs. 4.37 mg/ml, P < 0.018).
  • 3
    IgA levels were highest in participants with motor complete injuries compared to uninjured participants (P < 0.0003).

Research Summary

This study compared circulating antibody levels in individuals with chronic SCI and uninjured controls, revealing significantly elevated IgA and IgG2 levels in the SCI group. Elevated IgA levels correlated with motor complete injuries and injuries rostral to T5, suggesting a link between injury severity/level and immune response. The findings highlight potential immune dysregulation in chronic SCI and warrant further investigation into antibody responses, particularly in the context of infectious diseases.

Practical Implications

Infection Risk

Elevated IgA and IgG2 levels could indicate an altered immune response to infections in individuals with SCI.

Therapeutic Targets

Understanding the role of IgA and IgG2 could lead to new therapeutic strategies to improve immune function in SCI.

COVID-19 Implications

Further research is needed to understand how these altered antibody levels affect responses to emerging infectious diseases like COVID-19 in individuals with SCI.

Study Limitations

  • 1
    Pilot study with a sample size of convenience.
  • 2
    Mechanism of injury most common among participants with SCI was sports, which does not mirror the national population.
  • 3
    Many factors that can impact adaptive immunity that we did not control for.

Your Feedback

Was this summary helpful?

Back to Spinal Cord Injury